45 results match your criteria: "Bakirkoy Prof Mazhar Osman Training and Research Hospital for Psychiatry[Affiliation]"

Objective: In the current study, we aimed to investigate fasting plasma levels of glucose, insulin, growth hormone, IGF-1, and lipid profile in remission schizophrenia patients, treatment resistant schizophrenia patients and healthy controls and to determine whether IGF-1 levels can be used as a theranostic biomarker in schizophrenia.

Methods: Sixty-two patients under remission from schizophrenia, sixty-five treatment-resistant patients with schizophrenia and sixty-two healthy controls were included in the study. All patients were recruited and evaluated over 11 months.

View Article and Find Full Text PDF
Article Synopsis
  • The CNS effects of SARS-CoV-2 infection and the neuropsychiatric impact of COVID-19 treatments remain unclear.
  • A case study of a 43-year-old woman revealed new-onset psychotic symptoms, possibly linked to either the virus or her medications.
  • This highlights the need for careful neuropsychiatric monitoring in COVID-19 patients and awareness of the safety profiles of treatments.
View Article and Find Full Text PDF

Melatonin (MLT) is a hormone secreted by the pineal gland according to the circadian rhythm, which is generated by the suprachiasmatic nucleus. The sleep-promoting effect of exogenous MLT is used to treat sleep disorders. The most common side effects reported are headache, somnolence, palpitations, and abdominal pain.

View Article and Find Full Text PDF

Despite neuropsychiatric outcomes of SARS-CoV-2 infection are now under close scrutiny, psychoneuroimmunological characteristics of COVID-19 and precise pathophysiology of neuropsychiatric manifestations of the infection are still obscure. Moreover, there still exists a shortfall in demonstrating specific clinical manifestations of the brain involvement of the virus. Here, we presented a 33-year-old female patient with COVID-19, reporting acute-onset paranoid delusions symptoms, insomnia and irritability.

View Article and Find Full Text PDF

Cognitive impairment has recently attracted researchers as one of the possible neuropsychiatric manifestations of COVID-19, although how the infection perpetuates impairment of cognitive functions is still obscure. We presented a 29-year-old male patient with COVID-19 who developed new-onset transient attention deficit and memory problems following a SARS-CoV-2 infection. Structural neuroimaging was normal.

View Article and Find Full Text PDF
Article Synopsis
  • Receptor binding plays a key role in determining which tissues SARS-CoV-2 can infect.
  • SARS-CoV-2 shows neurotropism, meaning it can infect the central nervous system (CNS) by interacting with various receptors.
  • Sigma receptors may play a role in how SARS-CoV-2 transmits within neurons.
View Article and Find Full Text PDF
Article Synopsis
  • A 22-year-old man with schizophrenia experienced persistent positive symptoms, such as hallucinations and delusions, despite extensive treatment with various antipsychotics before starting clozapine monotherapy for 4 months.
  • A combination of aripiprazole long-acting injection was introduced after the ineffective clozapine treatment, leading to significant improvement in positive symptoms and increased social interaction noted by caregivers.
  • This case suggests that for some schizophrenia patients who do not fully respond to clozapine alone, adding aripiprazole may offer a beneficial therapeutic approach.
View Article and Find Full Text PDF

Objective: Peripheral biomarker studies in schizophrenia are insufficient to correspond to whether inflammatory markers are trait- or state-related. The main objective of this study was to compare novel biomarkers C-reactive protein/albumin ratio (CAR), neutrophil/albumin ratio (NAR), and complete blood count-derived inflammatory markers; neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (MLR), red-cell distribution width (RDW), and mean platelet volume (MPV) between patients with acutely exacerbated and remitted schizophrenia and healthy controls.

Methods: Anonymous data of a total of 618 patients with schizophrenia (179 in remission, 439 with acute exacerbation) and 445 psychiatrically and medically healthy subjects admitted to outpatient units were included.

View Article and Find Full Text PDF

Objective: Several lines of evidence support a relationship between circadian rhythms disruption in the onset, course, and maintenance of mental disorders. Despite the study of circadian phenotypes promising a decent understanding of the pathophysiologic or etiologic mechanisms of psychiatric entities, several questions still need to be addressed. In this review, we aimed to synthesize the literature investigating chronobiologic theories and their associations with psychiatric entities.

View Article and Find Full Text PDF

Organic brain disturbances particularly related to frontal cortex structures and subcortical areas including the basal ganglia may play a role in behavioral disinhibition disorders. Kluver-Bucy syndrome (KBS), which is one of the better knowns of these syndromes, includes hyperorality, visual agnosia, and hypersexuality, has been reported to occur after temporal lobe and amygdala lesions; however, several patients who had focal lesions in areas other than the temporal cortex and amygdala have been reported to present partial KBS symptoms. Nucleus lentiformis refers to a large portion of the basal ganglia including the putamen and globus pallidus, and specific structures within this broad area are known to be important for reward and value-based decision making.

View Article and Find Full Text PDF

• Neuropsychiatric manifestations of COVID-19 have been started reporting. • Nervous system involvement of SARS-CoV-2 are yet to be elucidated. • COVID-19 may involve both neuroimmune response and direct viral transmission.

View Article and Find Full Text PDF

Objective: To examine the association between clinical and treatment characteristics and antidepressants (AD)-induced manic switch in bipolar disorder (BD).

Methods: Total of 238 euthymic BD patients, who had been followed-up for at least 6 months at the outpatient clinic of Haseki Training and Research Hospital in istanbul, Turkey, were enrolled in this cross-sectional study in 2016. Semi-structured data form, the mood chart, and the mirror-designated assessment were applied to all subjects.

View Article and Find Full Text PDF